# Fujian Shengdi Pharmaceutical Co., Ltd.

Organization · id `cardio:org-fujian-shengdi-pharmaceutical-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Fujian+Shengdi+Pharmaceutical+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Fujian Shengdi Pharmaceutical Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects (`cardio:ct-nct05966272`)
- Sponsors: A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes (`cardio:ct-nct06649344`)
- Sponsors: the Efficacy and Safety of HRS9531 Injection in Subjects With Type 2 Diabetes， Inadequately Controlled With Diet and Exercise Alone (`cardio:ct-nct06650007`)
- Sponsors: Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin (`cardio:ct-nct07060456`)
- Sponsors: A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia (`cardio:ct-nct07100418`)
- Sponsors: HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke. (`cardio:ct-nct07233070`)
- Sponsors: A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease (`cardio:ct-nct07551492`)
- Sponsors: A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia (`cardio:ct-nct07799688`)
- Sponsors: A Study of HRS-4729 Injection in Participants With Type 2 Diabetes (`cardio:ct-nct07843862`)

## Provenance

Content hash: 171537e5d1906798921b84210de0af4a2189c11219899a920b311a0cc4d789f3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
